Oligomerization of Yeast Prion Sup35NM

WANG YanJing,WU Chi
DOI: https://doi.org/10.1360/n052018-00022
2018-01-01
Abstract:We have studied the misfolding process of a neurodegenerative disease-related protein, yeast prion Sup35NM, especially the initial oligomerization prcoess. To slow down the aggregation rate of Sup35NM in phasphate buffer saline in vitro , we conjugated a commercial available maleimide terminated-poly( N -isopropylacrylamide) (PNIPAM) molecule at the specific 31st residue site on Sup35NM by site-directed mutagenesis and thiol-ene click chemistry, which results in a Sup35NM-31m-PNIPAM conjugate. The aggregation process of Sup35NM was hindered after modification by PNIPAM at 25°C. The ThT fluorescence assay provided a time window for studying the oligomerization prcoess (or lag phase) of Sup35NM (~10 h) and the Sup35NM-31m-PNIPAM conjugate (~24 h) based on the onset of the fluorescence intensity. Further, the results of LLS confirmed the inhibition effect of PNIPAM modification on the oligomerization of Sup35NM due to its high sensitivity on the small aggregates. Finally, the Smoluchowski coagulation equation was adopted to analyze the data from laser light scattering, which provides us quantitative results on the lag phase kinetics and oligomer distribution of the two samples during the initial 6 h upon aggregation. The results show that there only exsits ~13% monomers in the sample of the Sup35NM at 6 h after initiating the protein association process, while nearly half of the protein chains exsit as monomers for the Sup35NM-31m-PNIPAM conjugate. In summary, the current work provides a controlable and quantative way to study the oligomerization behavior of the amyloidogenic proteins.
What problem does this paper attempt to address?